' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Angiotensin converting enzyme has an inhibitory role in CGRP metabolism in human skin.
Krämer, HH; Schmidt, K; Leis, S; Schmelz, M; Sommer, C; Birklein, F;
Peptides. 2006; 27(4):917-920
Originalarbeiten (Zeitschrift)

PMU-Autor/inn/en

Leis Stefan

Abstract

The neutral endopeptidase (NEP) is important for calcitonin gene related peptide (CGRP) degradation, while the role of angiotensin converting enzyme (ACE) remains unclear. By using dermal microdialysis we explored the effect of phosphoramidon (NEP blocker), captopril (ACE blocker) and a mixture of both drugs on the intensity of electrically-induced CGRP-mediated neurogenic flare. The results reveal that phosphoramidon elevated flare intensity, but that this was not further increased by adding captopril. In contrast, neurogenic flare was decreased when the drug mixture was applied in compared to NEP only. Electrically released CGRP levels could be measured directly in perfusates containing phosphoramidon and the mixture. Again, CGRP levels were elevated in phosphoramidon treated sites, and significantly reduced upon adding captopril. These findings suggest that NEP and ACE do not have additive effects regarding neuropeptide degradation. In contrast, inhibition of ACE seems to augment CGRP catabolism.


Useful keywords (using NLM MeSH Indexing)

Adult

Angiotensin-Converting Enzyme Inhibitors/pharmacology

Calcitonin Gene-Related Peptide/antagonists*

inhibitors*

Calcitonin Gene-Related Peptide/metabolism*

Captopril/pharmacology

Female

Glycopeptides/pharmacology

Humans

Laser-Doppler Flowmetry

Male

Peptidyl-Dipeptidase A/metabolism*

Retrograde Degeneration

Skin/metabolism*

Vasodilation/drug effects